M
Metabolon
Provides actionable biological insights to answer the toughest questions in life sciences research and drug development
About Metabolon
Metabolon, Inc. specializes in providing advanced metabolomics solutions, which involve the large-scale study of small molecules called metabolites within cells, biofluids, tissues, or organisms. The company serves a diverse range of clients, including academic researchers, pharmaceutical companies, and government institutions. Operating in the biotechnology and life sciences market, Metabolon offers a comprehensive suite of services from study design and sample collection to data analysis and biological interpretation. The business model is service-based, generating revenue through contracts and collaborations for metabolomic analysis projects. Metabolon leverages its extensive compound library and integrated bioinformatics platform to deliver high-fidelity results, ensuring reliable and actionable insights for its clients. The company has successfully completed over 10,000 projects for more than 1,300 clients, demonstrating its expertise and reliability in the field.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2000
- Headquarters
- Morrisville, United States
- Employees
- 202
- Open positions
- 3
- Dealroom signal
- 78.6/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Diabetes, Testing, Biotechnology, Drug Development, Biomarkers, Precision Medicine, Spinout, Biotech and Pharma, Horizon Europe, medical testing
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 2 companies, latest Sep 2017
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Jun 2024 | $0 | — | National Institutes of Health | ↗ |
| DEBTDebt | May 2024 | $60M | — | Trinity Capital | ↗ |
Growth signals
Latest recorded traffic for Metabolon is 43K monthly website visits, up 59.3% over the last three months. Metabolon's team grew 2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Metabolomic DiscoveriesPotsdam, GermanyMetabolon | Metabolomics for Research and Clinic
$3.2Mvaluation
LT
Lipomics TechnologiesWest Sacramento, United StatesMetabolon | Metabolomics for Research and Clinic
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Institutes of Health
Series A3 investors entered at this stage
Aurora Funds
Sevin Rosen Funds
180 Degree Capital
Series B and later9 investors entered at this stage
- BVBDCA Venture
Fletcher Spaght Ventures
Global Crossroads Capital
Syngenta Ventures
Camden Partners
Essex Woodlands Health Ventures
Perceptive Advisors
EW Healthcare Partners
Trinity Capital
Other known investors1 additional known investor
Duke University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Metabolon on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Metabolon’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.